In today’s 340B environment, conversations about manufacturer-requested data often turn on a simple assumption: that the requested data is the same information covered entities already send to commercial insurers, Medicare, or Medicaid. But 340B operations are not always that simple. In many programs, payer claims are submitted before a 340B determination has been made, which means the claim sent for adjudication may not identify the dispense as 340B.

In this episode of Katy’s 340B Compass, Katy Lees breaks down why timing, claim adjudication, accumulation, replenishment, reversals, eligibility logic, and third-party administrator processes all matter when evaluating 340B data-sharing requests. This discussion is especially relevant for health system executives, compliance leaders, pharmacy leaders, and 340B teams working through data strategy, risk exposure, and operational decision-making.

Katy Lees, Principal 340B Compliance Advisor at Virtue 340B, brings a practical and balanced perspective to a complex issue. Rather than taking a position on whether manufacturer data-sharing requirements are appropriate, she focuses on helping covered entities understand the operational facts, evaluate risks clearly, and make decisions grounded in their own systems, contracts, patient impact, and compliance considerations.

Visit Virtue 340B’s episode landing page at https://virtue340b.com/content-hub__t… to watch this episode and explore other available viewing and listening options. Watch Now >